查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462911

間質幹細胞市場，按產品類型、應用、最終用途、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Mesenchymal Stem Cells Market, By Product Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 310 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年間質幹細胞市場規模為 34.54 億美元，2024 年至 2032 年複合CAGR為 11.5%。

間質幹細胞市場-市場動態

再生醫學偏好拉動市場需求

間質幹細胞已成為再生醫學領域非常有用的工具。它們可以從許多組織中提取，例如牙髓、脂肪組織、骨髓和臍帶。由於間質幹細胞具有分化成多種組織類型的能力及其免疫調節特性，因此擴大使用間質幹細胞來修復受損或退化的組織，從而極大地支持了市場。鑑於對組織損傷和慢性疾病的有效療法的需求不斷成長，再生醫學市場預計在不久的將來將會擴大。此外，MSC 的廣泛使用有助於骨折、軟骨畸形、韌帶損傷和肌腱損傷的癒合，對該行業產生了積極影響。透過將間質幹細胞直接注射到受傷部位，可以促進組織再生並減少炎症，從而改善效果並加速癒合過程。隨著人口老化和肌肉骨骼疾病盛行率的上升，預計基於間質幹細胞的療法將在骨科領域越來越受歡迎。

間質幹細胞市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 11.5% 左右的CAGR成長

根據產品類型細分，骨髓細分市場預計將在預測期內主導市場

根據應用細分，治療領域預計將在預測期內引領市場成長

按地區分類，北美是 2023 年的主要收入來源

間質幹細胞市場-細分分析：

全球間質幹細胞市場根據產品類型、應用、最終用途和地區進行細分。

根據產品類型，市場分為脂肪組織、骨髓、臍帶和其他。預計骨髓細分市場將在預測期內主導市場。骨髓間質幹細胞一直是許多研究的主題，並被認為是該領域最好的。這些細胞具有分化成多種細胞類型的能力，包括脂肪細胞、軟骨細胞和成骨細胞。這項特性使其能夠用於廣泛的治療應用，例如發炎和免疫疾病以及骨科和肌肉骨骼疾病的治療。此外，間質幹細胞可以經常從骨髓中獲得，這使其成為科學家和醫療從業者的熱門選擇。

根據應用，市場分為研究、治療和其他。預計治療領域將在預測期內引領市場成長。間質幹細胞在治療一系列疾病和創傷方面顯示出良好的效果，例如燒傷、自體免疫疾病、心臟和神經系統問題、骨骼和軟骨異常以及自體免疫疾病。隨著越來越多的臨床試驗和學術研究證明間質幹細胞的安全性和有效性，間質幹細胞在再生醫學的應用越來越多。此外，預計糖尿病和癌症等慢性疾病發病率的上升將增加對基於 MSC 的療法的需求。

根據最終用途，該行業分為肌肉骨骼、骨科、腫瘤、心血管和其他。

間質幹細胞市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美在預測期內將佔據大部分市場佔有率。在美國，正在進行大量臨床試驗，以評估間質幹細胞作為一系列嚴重疾病的潛在治療方法的安全性和有效性。此外，北美擁有相當一部分參與間質幹細胞供應和商業化的最大公司。此外，對新療法的需求不斷成長，鼓勵性的政府政策以及產業參與者加強努力創造複雜的間質幹細胞療法來治療慢性疾病。這些因素對該地區的商業霸主地位發揮了作用。

間質幹細胞市場-競爭格局：

市場的主要參與者包括武田藥品工業株式會社、默克公司、賽默飛世爾科技公司、Lonza Group Ltd、Stemcell Technologies, Inc.、Cellular Dynamics International, Inc.、Regeneus Ltd、Tissue Genesis, Inc. 、Cesca Therapeutics Inc.和伊普森。這些參與者採取了各種策略，如產品推出、擴張、投資、合作等，以獲得最大的市場佔有率。

最近的發展：

2023 年 5 月，透過與 Histocell 合作，REPROCELL 將提供 CDMO 服務，生產由間質幹細胞 (MSC) 製成的先進療法藥物產品 (ATMP)。 REPROCELL 的分包合作夥伴 Histocell 經授權在西班牙畢爾巴鄂開設了 GMP ATMP 生產工廠。自2008年以來，Histocell一直提供GMP製造服務。該公司在生產治療性 MSC 產品方面擁有豐富的經驗，例如外泌體細胞治療和無細胞 MSC 衍生的分泌組。

目錄

第1章：間質幹細胞市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的間質幹細胞市場片段
    • 間質幹細胞市場片段（依應用）
    • 依最終用途分類的間質幹細胞市場片段
    • 按國家/地區分類的間質幹細胞市場片段
    • 按地區分類的間質幹細胞市場片段
  • 競爭洞察

第 3 章：間質幹細胞主要市場趨勢

  • 間質幹細胞市場促進因素
    • 市場促進因素的影響分析
  • 間質幹細胞市場限制
    • 市場限制影響分析
  • 間質幹細胞市場機會
  • 間質幹細胞市場未來趨勢

第 4 章：間質幹細胞產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：間質幹細胞市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：間質幹細胞市場格局

  • 2023 年間質幹細胞市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：間質幹細胞市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 脂肪組織
    • 骨髓
    • 臍帶
    • 其他

第 8 章：間質幹細胞市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 研究
    • 治療性
    • 其他

第 9 章：間質幹細胞市場 - 依最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院
    • 肌肉骨骼
    • 骨科
    • 腫瘤學
    • 心血管
    • 其他

第 10 章：間質幹細胞市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美間質幹細胞主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲間質幹細胞主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區間質幹細胞主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲間質幹細胞主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲間質幹細胞主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 間質幹細胞產業

  • 競爭儀表板
  • 公司簡介
    • Takeda Pharmaceutical Company Limited
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Lonza Group Ltd
    • Stemcell Technologies, Inc.
    • Cellular Dynamics International, Inc.
    • Regeneus Ltd
    • Tissue Genesis, Inc.
    • Cesca Therapeutics Inc
    • Ipsen

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究最終用途學
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2369

REPORT HIGHLIGHT

Mesenchymal Stem Cells Market size was valued at USD 3,454 Million in 2023, expanding at a CAGR of 11.5% from 2024 to 2032.

Within the field of regenerative medicine, adult stem cells known as mesenchymal stem cells (MSCs) exhibit great potential. Bone marrow, adipose tissue (fat), umbilical cord blood, and dental pulp are among the tissues in the body that contain them. Osteoblasts, chondrocytes, myocytes, fat cells, and muscle cells are just a few of the cell types that can be created from MSCs because to their amazing capacity to differentiate.

Mesenchymal Stem Cells Market- Market Dynamics

Preference for regenerative medicine to propel market demand

MSCs have become a very useful tool in the field of regenerative medicine. They can be extracted from a number of tissues, such as tooth pulp, adipose tissue, bone marrow, and umbilical cord. The market is being substantially supported by the increasing use of MSCs for the repair of damaged or degenerated tissues because of their capacity to differentiate into a variety of tissue types and their immunomodulatory qualities. Given the rising need for efficient therapies for tissue damage and chronic illnesses, the market for regenerative medicine is expected to expand in the near future. Furthermore, the industry is being positively impacted by the widespread use of MSCs to aid in the healing of fractures, cartilage deformities, ligament injuries, and tendon injury. It is feasible to promote tissue regeneration and decrease inflammation by injecting MSCs directly into the injured area, improving results and hastening the healing process. MSC-based therapies are predicted to become increasingly popular in orthopedics as the aging population and the prevalence of musculoskeletal disorders rise.

Mesenchymal Stem Cells Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2024-2032)

Based on product type segmentation, the Bone Marrow segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Therapeutic segment is expected to lead the market growth during the forecast period

Based on region, North America was the leading revenue generator in 2023

Mesenchymal Stem Cells Market- Segmentation Analysis:

The Global Mesenchymal Stem Cells Market is segmented based on Product Type, Application, End-Use, and Region.

Based on the product type, the market is categorized into Adipose Tissue, Bone Marrow, Umbilical Cord and Others. The Bone Marrow segment is expected to dominate the market over the forecast period. Bone marrow-derived mesenchymal stem cells have been the subject of much study and are considered the best in their area. These cells have the ability to differentiate into a variety of cell types, including adipocytes, chondrocytes, and osteoblasts. This characteristic enables its use in a wide range of therapeutic applications, such as the management of inflammatory and immunological diseases as well as orthopedic and musculoskeletal conditions. Moreover, mesenchymal stem cells may be obtained from bone marrow quite frequently, which makes it a popular choice for scientists and medical practitioners.

Based on the application, the market is divided into Research, Therapeutic and Others. The Therapeutic segment is expected to lead the market growth during the forecast period. MSCs have shown promising results in the treatment of a range of ailments and traumas, such as burns, autoimmune disorders, heart and neurological issues, anomalies of the bone and cartilage, and autoimmune diseases. MSCs are being used more and more in regenerative medicine as more clinical trials and scholarly research demonstrate their safety and efficacy. Furthermore, it is anticipated that the rising incidence of chronic illnesses like diabetes and cancer would increase demand for MSC-based therapies.

Based on the end-use, the industry is divided into Musculoskeletal, Orthopedics, Oncology, Cardiovascular and Others.

Mesenchymal Stem Cells Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the majority of market share during the forecast period. In the United States, a significant number of clinical trials are being conducted to evaluate the safety and effectiveness of mesenchymal stem cells as a potential treatment for a range of serious illnesses. Moreover, North America is home to a sizable portion of the largest corporations involved in the supply and commercialization of MSCs. Furthermore, there is a growing need for novel treatments, encouraging government policies, and heightened endeavors by industry players to create sophisticated mesenchymal stem cell treatments for the treatment of chronic diseases. These elements have played a part in the region's commercial supremacy.

Mesenchymal Stem Cells Market- Competitive Landscape:

The key players in the market are Takeda Pharmaceutical Company Limited, Merck KGaA, Thermo Fisher Scientific, Inc., Lonza Group Ltd, Stemcell Technologies, Inc. Cellular Dynamics International, Inc. Regeneus Ltd, Tissue Genesis, Inc., Cesca Therapeutics Inc and Ipsen. These players adopted various strategies such as product launch, expansion, investment, collaboration, and others to obtain the maximum market share of the market.

Recent Developments:

In May 2023, through a collaboration with Histocell, REPROCELL will now provide CDMO services to produce Advanced Therapies Medicinal Products (ATMPs) made from mesenchymal stem cells (MSC). Histocell, a subcontracting partner of REPROCELL, has opened a GMP ATMP production plant in Bilbao, Spain, with authorization. Since2008, Histocell has been offering GMP manufacturing services. The company has extensive experience producing therapeutic MSC products, such as exosome cell treatments and cell-free MSC-derived secretome.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MESENCHYMAL STEM CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Takeda Pharmaceutical Company Limited

Merck KGaA

Thermo Fisher Scientific, Inc.

Lonza Group Ltd

Stemcell Technologies, Inc.

Cellular Dynamics International, Inc.

Regeneus Ltd

Tissue Genesis, Inc.

Cesca Therapeutics Inc

Ipsen

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Adipose Tissue
  • Bone Marrow
  • Umbilical Cord
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Research
  • Therapeutic
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Musculoskeletal
  • Orthopedics
  • Oncology
  • Cardiovascular
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Mesenchymal Stem Cells Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Mesenchymal Stem Cells Market Snippet by Product Type
    • 2.1.2.Mesenchymal Stem Cells Market Snippet by Application
    • 2.1.3.Mesenchymal Stem Cells Market Snippet by End-Use
    • 2.1.4.Mesenchymal Stem Cells Market Snippet by Country
    • 2.1.5.Mesenchymal Stem Cells Market Snippet by Region
  • 2.2.Competitive Insights

3.Mesenchymal Stem Cells Key Market Trends

  • 3.1.Mesenchymal Stem Cells Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Mesenchymal Stem Cells Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Mesenchymal Stem Cells Market Opportunities
  • 3.4.Mesenchymal Stem Cells Market Future Trends

4.Mesenchymal Stem Cells Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Mesenchymal Stem Cells Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Mesenchymal Stem Cells Market Landscape

  • 6.1.Mesenchymal Stem Cells Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Mesenchymal Stem Cells Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Adipose Tissue
    • 7.1.3.Bone Marrow
    • 7.1.4.Umbilical Cord
    • 7.1.5.Others

8.Mesenchymal Stem Cells Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Research
    • 8.1.3.Therapeutic
    • 8.1.4.Others

9.Mesenchymal Stem Cells Market - By End-Use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2.Hospitals
    • 9.1.3.Musculoskeletal
    • 9.1.4.Orthopedics
    • 9.1.5.Oncology
    • 9.1.6.Cardiovascular
    • 9.1.7.Others

10.Mesenchymal Stem Cells Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Mesenchymal Stem Cells Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Mesenchymal Stem Cells Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Mesenchymal Stem Cells Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Mesenchymal Stem Cells Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Mesenchymal Stem Cells Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Mesenchymal Stem Cells Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Takeda Pharmaceutical Company Limited
    • 11.2.2.Merck KGaA
    • 11.2.3.Thermo Fisher Scientific, Inc.
    • 11.2.4.Lonza Group Ltd
    • 11.2.5.Stemcell Technologies, Inc.
    • 11.2.6.Cellular Dynamics International, Inc.
    • 11.2.7.Regeneus Ltd
    • 11.2.8.Tissue Genesis, Inc.
    • 11.2.9.Cesca Therapeutics Inc
    • 11.2.10.Ipsen

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research End-Useology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Mesenchymal Stem Cells Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Mesenchymal Stem Cells Market, by Product Type 2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Mesenchymal Stem Cells Market, by Application 2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: End-UseSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Mesenchymal Stem Cells Market, by End-Use2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Mesenchymal Stem Cells Market, by Region 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)